Compare IBIO & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBIO | HAIN |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0M | 53.7M |
| IPO Year | 2009 | 1996 |
| Metric | IBIO | HAIN |
|---|---|---|
| Price | $0.76 | $0.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $5.69 | $1.50 |
| AVG Volume (30 Days) | 858.9K | ★ 1.2M |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.71 | 42.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,457,769,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.73 | $0.24 |
| 52 Week High | $3.82 | $1.64 |
| Indicator | IBIO | HAIN |
|---|---|---|
| Relative Strength Index (RSI) | 19.34 | 23.98 |
| Support Level | N/A | N/A |
| Resistance Level | $1.52 | $0.64 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 6.77 | 9.04 |
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.